CHER Trial
20 November 2008
A landmark South African study conducted in Soweto and
Cape Town, has shown that administering antiretroviral therapy
(ART) to infants immediately after diagnosis, rather than waiting
for their CD4 counts to drop or other symptoms to prompt treatment,
reduced their chance of dying by 76%.
It also reduced the chance of their disease progressing
measurably by 75%. The findings were so conclusive that after
review of the preliminary data, all the babies in the trial were
re-assessed for ART.
Read the full Press
Release
Last Update Date : 7/6/2009
